Decryption of the retinoid death code in leukemia

Journal of Clinical Immunology

Volumn 22, Issue 3, 2002, Pages 117-123

  Altucci, Lucia ^a   Gronemeyer, Hinrich ^a  

^a Institut de Ganatique et de Biologie Moleculaire et Cellulaire   (Germany)

Author keywords

Death signaling; Leukemia; PKA cross talk; Retinoid and rexinoid; Survival factors; TRAIL

Indexed keywords

RETINOID; CYCLIC AMP DEPENDENT PROTEIN KINASE; RECEPTOR BLOCKING AGENT; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR ANTAGONIST; RETINOID X RECEPTOR; RETINOID X RECEPTOR ANTAGONIST; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; DRUG EFFECT; HUMAN; LEUKEMIA; PATHOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; CELL DEATH; CELL MATURATION; CONFERENCE PAPER; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

APOPTOSIS; HUMANS; LEUKEMIA; RECEPTOR CROSS-TALK; RETINOIDS; SIGNAL TRANSDUCTION;

EID: 0036260386     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015490627613     Document Type: Article

References (51)

1. Embryonic retinoic acid synthesis is essential for early mouse postimplantation development
2. Retinoic acid receptor-beta: An endogenous inhibitor of the perinatal formation of pulmonary alveoli
3. Selective ablation of retinoid X receptor alpha in hepatocytes impairs their lifespan and regenerative capacity
4. Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver
5. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL
6. Essential roles of retinoic acid signaling in interdigital apoptosis and control of BMP-7 expression in mouse autopods
7. Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development
8. Combinatorial roles of the nuclear receptor corepressor in transcription and development
9. Nuclear receptor ligand-binding domains: Three-dimensional structures, molecular interactions and pharmacological implications
10. The coregulator exchange in transcriptional functions of nuclear receptors
11. The TRAP/SMCC/Mediator complex and thyroid hormone receptor function
12. The mechanism of action of thyroid hormones
13. Steroid/nuclear receptor coactivators
14. Mediator complexes and transcription
15. Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia
16. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia
17. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co- repressors determine differential responses to RA in APL
18. Role of the histone deacetylase complex in acute promyelocytic leukaemia
19. Oligomerization of RAR and AML 1 transcription factors as a novel mechanism of oncogenic activation
20. Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers
21. PMLRAR homodimers: Distinct DNA binding properties and heteromeric interactions with RXR
22. Role of SUMO-1-modified PML in nuclear body formation
23. The transcriptional role of PML and the nuclear body
24. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha
25. Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family members
26. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis
27. Re1-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis
28. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-1AP2 is under NF-kappaB control
29. ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Re1 oncoprotein
30. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c- IAP2 to suppress caspase- 8 activation
31. Signal transduction. A cellular rescue team
32. IAP family proteins-Suppressors of apoptosis
33. The TRAIL to selective tumor death
34. All-trans-retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia
35. Hot on the TRAIL of acute promyelocytic leukemia
36. Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: The trail to non-toxic cancer therapeutics
37. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells
38. Retinoids selective for retinoid X receptor response pathways
39. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding
40. Unique response pathways are established by allosteric interactions among nuclear hormone receptors
41. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers
42. Modulation of human G-CSF receptor mRNA and protein in normal and leukemic myeloid cells by G-CSF and retinoic acid
43. Induction of high-affinity GM-CSF receptors during all-trans retinoic acid treatment of acute promyelocytic leukemia
44. Administration of granulocyte colony-stimulating factor during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia
45. Initial clinical trial of a selective retinoid X receptor ligand, LGD1069
46. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
47. Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia
48. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation
49. Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells
50. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain
51. Retinoid-X receptor signalling in the developing spinal cord